Skip to main content
. Author manuscript; available in PMC: 2011 Jan 3.
Published in final edited form as: Br J Health Psychol. 2009 Jul 13;15(Pt 2):321–335. doi: 10.1348/135910709X464353

Table 2.

Characteristics of participants

Characteristic Home (N = 138) Other (N = 279)
Age, years, mean (SD) 59.8 (11.2) 60.7 (11.6)
Female, number (%) 108 (78) 213 (76.9)
Race/ethnicity, number (%)
 Non-Hispanic White 103 (75) 225 (81)
 Black 20 (15) 26 (9)
 Other/declined to answer 15 (10) 28 (10)
Education level, number (%)
 ≤ 12 years 19 (14) 42 (15)
 13–15 years 53 (38) 108 (39)
 16 years 42 (30) 80 (29)
 > 16 years 24 (17) 42 (15)
 Declined to answer 0 (0) 5 (2)
Uninsured, number (%) 3 (2) 7 (3)
Chronic conditions, number (%)
 1 55 (40) 115 (41)
 2 51 (37) 105 (38)
 3 18 (13) 42 (15)
 ≥ 4 14 (10) 15 (5)
Specific study diagnoses, number (%)a
 Arthritis 83 (60) 150 (54)
 Depression 59 (43) 134 (48)
 Diabetes 64 (46) 108 (39)
 Asthma 34 (25) 64 (23)
 Congestive heart failure 17 (12) 31 (11)
 Chronic lung disease 15 (11) 28 (10)
Personality factors, mean (SD)
 Agreeableness 34.4 (4.8) 33.3 (5.7)
 Conscientiousness 31.3 (7.5) 32.0 (6.6)
 Extraversion 25.9 (8.0) 26.0 (7.3)
 Neuroticism 20.6 (9.9) 21.6 (9.2)
 Openness 28.2 (6.6) 28.7 (6.2)
MCS-36 scores, mean (SD)
 Baseline 45.6 (14.2) 45.5 (13.7)
 2 week follow-up 48.7 (13.8) 47.0 (13.1)
 4 week follow-up 51.2 (11.7) 48.9 (12.8)
 6 week follow-up 51.6 (12.1) 48.7 (12.5)
 6 month follow-up 49.6 (13.7) 47.1 (13.3)
 1 year follow-up 51.2 (12.1) 48.4 (12.4)
PCS-36 scores, mean (SD)
 Baseline 33.6 (12.0) 33.9 (11.7)
 2 week follow-up 35.4 (11.9) 36.1 (11.3)
 4 week follow-up 34.9 (12.3) 36.9 (11.6)
 6 week follow-up 34.9 (11.9) 36.8 (11.3)
 6 month follow-up 36.2 (12.0) 37.3 (11.6)
 1 year follow-up 35.1 (12.2) 36.7 (11.9)

Note. Other, telephone intervention and control groups combined; SD, standard deviation; MCS-36, SF-36 mental component summary score; PCS-36, SF-36 physical component summary score.

a

Percentages exceed 100 because many participants had more than one condition.